دورية أكاديمية

Genetic inhibition of autophagy in a transgenic mouse model of anal cancer.

التفاصيل البيبلوغرافية
العنوان: Genetic inhibition of autophagy in a transgenic mouse model of anal cancer.
المؤلفون: Rademacher, Brooks L., Meske, Louise M., Matkowskyj, Kristina A., Hanlon, Bret M., Carchman, Evie H.
المصدر: Journal of Carcinogenesis; 7/23/2018, Vol. 17, p1-11, 11p
مصطلحات موضوعية: ANAL cancer, TRANSGENIC mice, CARCINOGENS, KNOCKOUT mice, ONCOGENES
مستخلص: BACKGROUND: The dynamic role of autophagy in cancer development is a topic of considerable research and debate. Previously published studies have shown that anal cancer development can be promoted or prevented with the pharmacologic inhibition or induction, respectively, of autophagy in a human papillomavirus (HPV) mouse model. However, these results are confounded by the fact that the drugs utilized are known to affect other pathways besides autophagy. It has also been shown that autophagic inhibition occurs in the setting of HPV16 oncoprotein expression (E6 and E7) and correlates with increased susceptibility to anal carcinogenesis. MATERIALS AND METHODS: In this study, we employed a conditional, genetic, autophagic (Atg7) knockout mouse model to determine conclusively that autophagy has a role in anal cancer development, in the absence or presence of E6 and E7. RESULTS: In mice lacking both HPV16 oncogenes, knockout of autophagy followed by exposure to a carcinogen resulted in a tumor incidence of 40%, compared to 0% in mice treated with a carcinogen alone with an intact autophagic pathway (P = 0.007). In mice expressing either one or both HPV16 oncoproteins, the addition of genetic knockout of autophagy to carcinogen treatment did not lead to a significant difference in tumor incidence compared to carcinogen treatment alone, consistent with the ability of HPV oncogenes to inhibit autophagy in themselves. CONCLUSIONS: These results provide the first conclusive evidence for the distinct role of autophagy in anal carcinogenesis, and suggest that autophagy is a plausible target for therapies aimed at reducing anal dysplasia and anal cancer development. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Carcinogenesis is the property of Carcinogenesis Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09746773
DOI:10.4103/jcar.JCar_4_18